Moderna, Inc. (nasdaq mrna at https://www.webull.com/quote/nasdaq-mrna) is undergoing an incredible fortnight, with the antibody recognition by the Food and Drug Association (FDA) triggering a sell-the-news reaction that has taken the stock down to February. It’s down around six spots on…
